| Literature DB >> 35105314 |
Chenglong Luo1, Yiman Song1, Yiyang Liu1, Rui Wang1, Jianbo Gao1, Songwei Yue1, Changmao Ding2.
Abstract
BACKGROUND: As a rare benign lung tumour, pulmonary sclerosing pneumocytoma (PSP) is often misdiagnosed as atypical peripheral lung cancer (APLC) on routine imaging examinations. This study explored the value of enhanced CT combined with texture analysis to differentiate between PSP and APLC.Entities:
Keywords: Computed tomography; Peripheral lung cancer; Pulmonary sclerosing pneumocytoma; Texture analysis
Mesh:
Year: 2022 PMID: 35105314 PMCID: PMC8808962 DOI: 10.1186/s12880-022-00745-1
Source DB: PubMed Journal: BMC Med Imaging ISSN: 1471-2342 Impact factor: 1.930
Fig. 1A 50-year-old man with a diagnosis of PSP (A). CT image of venous phase showed a left pulmonary nodule. The nodule is about 2.2 cm in length and diameter, with obvious uniform enhancement and lobulation sign at the edge. Manually outline the ROI 1-2 mm along the inner side of the nodule edge, which is indicated by the green area. A 76-year-old man with a diagnosis of Peripheral lung cancer (B). The CT image of the venous phase showed a left pulmonary nodule with a length of about 2.3 cm, moderately and uniformly enhanced, with smooth edges and lobular signs. Draw the ROI manually 1–2 mm along the inner side of the nodule edge, indicated by the red area
Comparison of CT image features between PSP and APLC
| Imaging features | PSP (n = 48) | APLC (n = 50) | F-value (t/χ2) | |
|---|---|---|---|---|
| Maximum diameter (cm) | 1.9 ± 0.7 | 2.1 ± 0.6 | -1.741b | 0.085 |
| Shape | ||||
| Round or oval | 37 | 28 | 4.874a | 0.027 |
| Irregular | 11 | 22 | ||
| Plain CT value (HU) | 31.7 ± 11.6 | 30.4 ± 12.5 | 0.538b | 0.592 |
| CT value of the arterial phase (HU) | 72.1 ± 20.7 | 53.4 ± 18.6 | 4.704b | < 0.001 |
| CT value of the venous phase (HU) | 76.9 ± 19.8 | 60.5 ± 17.9 | 4.284b | < 0.001 |
| Degree of enhancement | ||||
| Mild | 4 | 15 | 13.551a | 0.001 |
| Moderate | 14 | 21 | ||
| Obvious | 30 | 14 | ||
| Mode of enhancement | ||||
| Uniform | 25 | 22 | 0.641a | 0.423 |
| Uneven | 23 | 28 | ||
| Air gap | 7 | 3 | 1.144a | 0.285 |
| Welt vessel sign | 27 | 22 | 1.470a | 0.225 |
| Halo sign | 6 | 5 | 0.154a | 0.695 |
| Calcification | 14 | 4 | 7.318a | 0.007 |
| Lobular sign | 10 | 24 | 7.977a | 0.005 |
| Liquefaction necrosis | 4 | 7 | 0.789a | 0.374 |
| Cavity | 1 | 4 | 0.760a | 0.383 |
PSP pulmonary sclerosing pneumocytoma, APLC atypical peripheral lung cancer
aPearson’s chi-square test
bIndependent-sample t test
Comparison of the best texture parameters between PSP and APLC
| Texture parameters | PSP | APLC | Z-value /t-value | |
|---|---|---|---|---|
| S(4,0)SumAverga | 81.0 ± 10.6 | 68.6 ± 9.2 | 5.693 | < 0.001 |
| Perc.01%a | 125.8 ± 22.1 | 100.1 ± 17.2 | 6.260 | < 0.001 |
| WavEnHL_s1b | 138.8 ± 183.2 | 54.5 ± 50.3 | − 5.493 | < 0.001 |
| 135dr_RLNonUnib | 143.2 ± 281.7 | 362.6 ± 469.7 | − 3.504 | < 0.001 |
Continuous variables in the table expressed as means ± SD or medians ± IQR
aMeans ± SD
bMedians ± IQR
Comparison of the effectiveness of each model in identifying PSP and APLC
| Model | AUC | Accuracy | Sensitivity | Specificity |
|---|---|---|---|---|
| Model A (CT image features) | 0.67 ± 0.05 | 0.68 ± 0.05 | 0.70 ± 0.11 | 0.65 ± 0.09 |
| Model B (CT texture parameters) | 0.72 ± 0.08 | 0.70 ± 0.06 | 0.68 ± 0.10 | 0.76 ± 0.15 |
| Model C (CT image features combined with texture parameters) | 0.84 ± 0.03 | 0.84 ± 0.04 | 0.82 ± 0.13 | 0.87 ± 0.12 |
Continuous variables in the table expressed as means ± SD
AUC area under the curve
Fig. 2The ROC curves of five-fold cross-validation. Three models including CT image features (A), CT texture parameters (B), and CT image features combined with texture parameters (C) were used to distinguish PSP and APLC